A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Stemtech Corporation and its Subsidiaries (collectively, the “Company”, or “Stemtech”) was incorporated in the State of Nevada, USA on September 4, 2009 under the name Globe Net Wireless Corp. with ticker symbol “GNTW”. Our corporate name was changed to Stemtech Corporation in the state of Nevada.in August 2021. We were listed on the OTCQB market under symbol “STEK” in April 2021. Stemtech is a global network marketing company that develops science-based products that it believes supports wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. Known as the Stem Cell Nutrition Company®, the Company is a pioneer in stem cell science, and believes it can demonstrate that adult stem cells function as the natural renewal system of the body.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 3.7M | 5.1M | 4.9M | 4.6M | 4.3M | 4.4M |
| Net Income | -3.3M | -3.8M | -5.4M | -8.5M | -7.1M | -917K |
| EPS | $-0.02 | $-0.03 | $-0.07 | $-0.19 | $-0.20 | $-0.10 |
| Free Cash Flow | 0 | -601K | -2.0M | -1.2M | -1.9M | -278K |
| ROIC | -53.4% | -49.8% | -90.6% | -93.0% | -44.3% | -71.3% |
| Gross Margin | 78.7% | 73.8% | 79.6% | 74.5% | 76.3% | 83.7% |
| Debt/Equity | 0.00 | -0.00 | -0.00 | -2.75 | -0.07 | 0.01 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -2.5M | -2.4M | -4.2M | -5.0M | -3.2M | -1.4M |
| Operating Margin | -67.8% | -47.2% | -85.8% | -110.2% | -74.3% | -32.7% |
| ROE | 0.0% | - | - | - | - | -72.3% |
| Shares Outstanding | 232M | 126M | 78M | 45M | 35M | 45M |
| Metric | 2020 | 2021 | 2022 | |||
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 4.4M | 4.3M | 4.6M | 4.9M | 5.1M | 3.7M |
| Gross Margin | 83.7% | 76.3% | 74.5% | 79.6% | 73.8% | 78.7% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -1.4M | -3.2M | -5.0M | -4.2M | -2.4M | -2.5M |
| Op. Margin | -32.7% | -74.3% | -110.2% | -85.8% | -47.2% | -67.8% |
| Net Income | -917K | -7.1M | -8.5M | -5.4M | -3.8M | -3.3M |
| Net Margin | -20.9% | -163.8% | -187.4% | -110.3% | -74.6% | -89.4% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | -71.3% | -44.3% | -93.0% | -90.6% | -49.8% | -53.4% |
| ROE | -72.3% | N/A | N/A | N/A | N/A | 0.0% |
| ROA | -18.3% | -123.7% | -200.3% | -147.4% | -101.0% | -89.2% |
| Cash Flow | ||||||
| Op. Cash Flow | -267K | -1.9M | -1.2M | -2.0M | -601K | -787K |
| Free Cash Flow | -278K | -1.9M | -1.2M | -2.0M | -601K | 0 |
| Owner Earnings | -1.1M | -3.4M | -5.7M | -3.1M | -1.4M | -1.6M |
| CapEx | 12K | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 430K | 429K | 447K | 588K | 344K | 344K |
| Growth CapEx | 0 | N/A | N/A | N/A | N/A | 0 |
| D&A | 430K | 429K | 447K | 588K | 344K | 344K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 451K | 1.0M | 4.0M | 439K | 440K | 440K |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||
| Net Debt | -115K | -609K | N/A | -114K | -255K | -255K |
| Cash & Equiv. | N/A | N/A | N/A | N/A | N/A | 255K |
| Long-Term Debt | 18K | 219K | N/A | 0 | 0 | N/A |
| Debt/Equity | 0.01 | -0.07 | -2.75 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | -9.0 | -0.4 | -1.2 | -0.9 | -1.5 | -1.5 |
| Equity | 1.3M | -3.4M | -2.4M | -2.0M | -4.5M | -5.8M |
| Total Assets | 5.0M | 5.7M | 4.3M | 3.7M | 3.8M | 3.8M |
| Total Liabilities | 3.7M | 9.1M | 6.7M | 5.7M | 8.3M | 10M |
| Intangibles | 4.3M | 3.9M | 3.5M | 3.2M | 2.8M | 2.8M |
| Retained Earnings | -6.0M | -13M | -22M | -27M | -31M | -31M |
| Working Capital | -3.2M | -7.8M | -6.8M | -6.1M | -8.1M | -8.1M |
| Current Assets | 573K | 1.6M | 612K | 401K | 922K | 922K |
| Current Liabilities | 3.7M | 9.4M | 7.4M | 6.5M | 9.0M | 9.0M |
| Per Share Data | ||||||
| EPS | -0.10 | -0.20 | -0.19 | -0.07 | -0.03 | -0.02 |
| Owner EPS | -0.03 | -0.10 | -0.13 | -0.04 | -0.01 | -0.01 |
| Book Value | 0.03 | -0.09 | -0.05 | -0.03 | -0.04 | -0.03 |
| Cash Flow/Share | -0.01 | -0.05 | -0.03 | -0.03 | -0.00 | -0.01 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 44.7M | 35.4M | 45.0M | 77.6M | 125.7M | 232.0M |
| Valuation | ||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | -0.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | 23.6 | 26.1 | 1.1 | 1.1 | 0.0 |
| FCF Yield | N/A | -2.2% | -27.1% | -79.8% | -10.4% | N/A |
| Market Cap | N/A | 88M | 4.5M | 2.6M | 5.8M | 46K |
| Avg. Price | N/A | 2.88 | 2.64 | 0.07 | 0.05 | 0.00 |
| Year-End Price | N/A | 2.50 | 0.10 | 0.03 | 0.05 | 0.00 |
Stemtech Corp passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 77.6%.
Stemtech Corp (STEK) has a 5-year average return on invested capital (ROIC) of -69.8%. This is below average and may indicate limited pricing power.
Stemtech Corp (STEK) has a market capitalization of $46K. It is classified as a small-cap stock.
Stemtech Corp (STEK) does not currently pay a regular dividend.
Stemtech Corp (STEK) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, within the Consumer Defensive sector.
Stemtech Corp (STEK) reported annual revenue of $5 million in its most recent fiscal year, based on SEC EDGAR filings.
Stemtech Corp (STEK) has a net profit margin of -74.6%. The company is currently unprofitable.
Stemtech Corp (STEK) generated $-601 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Stemtech Corp (STEK) has a debt-to-equity ratio of 0.00. This indicates a conservatively financed balance sheet.
Stemtech Corp (STEK) reported earnings per share (EPS) of $-0.03 in its most recent fiscal year.
Stemtech Corp (STEK) has a 5-year average gross margin of 77.6%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 5 years of financial data for Stemtech Corp (STEK), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Stemtech Corp (STEK) has a book value per share of $-0.04, based on its most recent annual SEC filing.
No recent press releases.